Prion disease blood test using immunoprecipitation and improved quaking-induced conversion

mBio

Volumn 2, Issue 3, 2011, Pages

  Orrú, Christina D ^a   Wilham, Jason M ^a   Raymond, Lynne D ^a   Kuhn, Franziska ^b   Schroeder, Björn ^b   Raeber, Alex J ^b   Caughey, Byron ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN M ANTIBODY; MONOCLONAL ANTIBODY 15B3; PRION PROTEIN; PROTEINASE K; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY AFFINITY; ARTICLE; BIOASSAY; BLOOD EXAMINATION; BRAIN HOMOGENATE; CONTROLLED STUDY; ENHANCED REAL TIME QUAKING INDUCED CONVERSION; HUMAN; HUMAN TISSUE; IMMUNOPRECIPITATION; IN VIVO STUDY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRION DISEASE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; SCRAPIE; SENSITIVITY ANALYSIS; SERUM; SYRIAN HAMSTER; VARIANT CREUTZFELDT JAKOB DISEASE; VIRUS DETECTION; ANIMAL; CHEMISTRY; EVALUATION; HAMSTER; METHODOLOGY; PLASMA; PRION; SENSITIVITY AND SPECIFICITY;

ANIMALIA; CRICETINAE;

ANIMALS; CRICETINAE; HEMATOLOGIC TESTS; HUMANS; IMMUNOPRECIPITATION; MESOCRICETUS; PLASMA; PRION DISEASES; PRIONS; SENSITIVITY AND SPECIFICITY; SERUM;

EID: 79960163849     PISSN: None     EISSN: 21507511     Source Type: Journal    
DOI: 10.1128/mBio.00078-11     Document Type: Article

References (45)

1. Caughey B, Baron GS, Chesebro B, Jeffrey M. 2009. Getting a grip on prions: oligomers, amyloids, and pathological membrane interactions. Annu. Rev. Biochem. 78:177-204.
2. Brown P, et al. 1998. The distribution of infectivity in blood components and plasma derivatives in experimental models of transmissible spongiform encephalopathy. Transfusion 38:810-816.
3. Manuelidis EE, Gorgacz EJ, Manuelidis L. 1978. Viremia in experimental Creutzfeldt-Jakob disease. Science 200:1069-1071.
4. Mathiason CK, et al. 2006. Infectious prions in the saliva and blood of deer with chronic wasting disease. Science 314:133-136.
5. Saá P, Castilla J, Soto C. 2006. Presymptomatic detection of prions in blood. Science 313:92-94.
6. Terry LA, et al. 2009. Detection of PrPsc in blood from sheep infected with the scrapie and bovine spongiform encephalopathy agents. J. Virol. 83:12552-12558.
7. Thorne L, Terry LA. 2008. In vitro amplification of PrPSc derived from the brain and blood of sheep infected with scrapie. J. Gen. Virol. 89: 3177-3184.
8. Vascellari M, et al. 2007. PrPSc in salivary glands of scrapie-affected sheep. J. Virol. 81:4872-4876.
9. Bessen RA, et al. 2010. Prion shedding from olfactory neurons into nasal secretions. PLoS Pathog. 6:e1000837.
10. Wilham JM, et al. 2010. Rapid end-point quantitation of prion seeding activity with sensitivity comparable to bioassays. PLoS Pathog. 6:e1001217.
11. Ironside JW. 2010. Variant Creutzfeldt-Jakob disease. Haemophilia 16(Suppl. 5):175-180.
12. Brown P. 2008. Transmissible spongiform encephalopathy in the 21st century: neuroscience for the clinical neurologist. Neurology 70:713-722.
13. Houston F, et al. 2008. Prion diseases are efficiently transmitted by blood transfusion in sheep. Blood 112:4739-4745.
14. Peden AH, Head MW, Ritchie DL, Bell JE, Ironside JW. 2004. Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient. Lancet 364:527-529.
15. Llewelyn CA, et al. 2004. Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion. Lancet 363:417-421.
16. Wroe SJ, et al. 2006. Clinical presentation and pre-mortem diagnosis of variant Creutzfeldt-Jakob disease associated with blood transfusion: a case report. Lancet 368:2061-2067.
17. Gregori L, et al. 2004. Effectiveness of leucoreduction for removal of infectivity of transmissible spongiform encephalopathies from blood. Lancet 364:529-531.
18. Saá P, Castilla J, Soto C. 2006. Ultra-efficient replication of infectious prions by automated protein misfolding cyclic amplification. J. Biol. Chem. 281:35245-35252.
19. Fujihara A, et al. 2009. Hyperefficient PrP Sc amplification of mouseadapted BSE and scrapie strain by protein misfolding cyclic amplification technique. FEBS J. 276:2841-2848.
20. Atarashi R, et al. 2008. Simplified ultrasensitive prion detection by recombinant PrP conversion with shaking. Nat. Methods 5:211-212.
21. Atarashi R, et al. 2007. Ultrasensitive detection of scrapie prion protein using seeded conversion of recombinant prion protein. Nat. Methods 4:645-650.
22. Colby DW, et al. 2007. Prion detection by an amyloid seeding assay. Proc. Natl. Acad. Sci. U. S. A. 104:20914-20919.
23. Trieschmann L, et al. 2005. Ultra-sensitive detection of prion protein fibrils by flow cytometry in blood from cattle affected with bovine spongiform encephalopathy. BMC Biotechnol. 5:26.
24. Orrú CD, et al. 2009. Human variant Creutzfeldt-Jakob disease and sheep scrapie PrP(res) detection using seeded conversion of recombinant prion protein. Protein Eng. Des. Sel. 22:515-521.
25. Bieschke J, et al. 2000. Ultrasensitive detection of pathological prion protein aggregates by dual-color scanning for intensely fluorescent targets. Proc. Natl. Acad. Sci. U. S. A. 97:5468-5473.
26. Chang B, et al. 2009. Surround optical fiber immunoassay (SOFIA): an ultra-sensitive assay for prion protein detection. J. Virol. Methods 159: 15-22.
27. Rubenstein R, et al. 2010. A novel method for preclinical detection of PrPSc in blood. J. Gen. Virol. 91:1883-1892.
28. Birkmann E, et al. 2008. A highly sensitive diagnostic assay for aggregaterelated diseases, including prion diseases and Alzheimer's disease. Rejuvenation Res. 11:359-363.
29. Birkmann E, et al. 2006. Detection of prion particles in samples of BSE and scrapie by fluorescence correlation spectroscopy without proteinaseK digestion. Biol. Chem. 387:95-102.
30. Edgeworth JA, et al. 2011. Detection of prion infection in variant Creutzfeldt-Jakob disease: a blood-based assay. Lancet 377:487-493.
31. Edgeworth JA, Jackson GS, Clarke AR, Weissmann C, Collinge J. 2009. Highly sensitive, quantitative cell-based assay for prions adsorbed to solid surfaces. Proc. Natl. Acad. Sci. U. S. A. 106:3479-3483.
32. Atarashi R, et al. 2011. Ultrasensitive human prion detection in cerebrospinal fluid by real-time quaking-induced conversion. Nat. Med. 17: 175-178.
33. LeVine H, III. 1999. Quantification of beta-sheet amyloid fibril structures with thioflavin T. Methods Enzymol. 309:274-284.
34. Korth C, et al. 1997. Prion (PrPSc)-specific epitope defined by a monoclonal antibody. Nature 390:74-77.
35. Biasini E, et al. 2009. Immunopurification of pathological prion protein aggregates. PLoS One 4:e7816.
36. Biasini E, et al. 2008. Non-infectious aggregates of the prion protein react with several PrPSc-directed antibodies. J. Neurochem. 105:2190-2204.
37. Jones M, et al. 2009. Human platelets as a substrate source for the in vitro amplification of the abnormal prion protein (PrP) associated with variant Creutzfeldt-Jakob disease. Transfusion 49:376-384.
38. Castilla J, et al. 2006. Protein misfolding cyclic amplification for diagnosis and prion propagation studies. Methods Enzymol. 412:3-21.
39. Miller MB, Supattapone S. 2011. Superparamagnetic nanoparticle capture of prions for amplification. J. Virol. 85:2813-2817.
40. Brown P. 2007. Creutzfeldt-Jakob disease: reflections on the risk from blood product therapy. Haemophilia 13(Suppl. 5):33-40.
41. Ferrone FA, Hofrichter J, Eaton WA. 1985. Kinetics of sickle hemoglobin polymerization. II. A double nucleation mechanism. J. Mol. Biol. 183: 611-631.
42. Padrick SB, Miranker AD. 2002. Islet amyloid: phase partitioning and secondary nucleation are central to the mechanism of fibrillogenesis. Biochemistry 41:4694-4703.
43. Panza G, et al. 2008. Spontaneous and BSE-prion-seeded amyloid formation of full length recombinant bovine prion protein. Biochem. Biophys. Res. Commun. 373:493-497.
44. Stöhr J, et al. 2008. Mechanisms of prion protein assembly into amyloid. Proc. Natl. Acad. Sci. U. S. A. 105:2409-2414.
45. Khan MQ, et al. 2010. Prion disease susceptibility is affected by betastructure folding propensity and local side-chain interactions in PrP. Proc. Natl. Acad. Sci. U. S. A. 107:19808-19813.